PF-04995274 and Emotional Processing in Treatment Resistant Depression

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

July 26, 2022

Study Completion Date

July 26, 2022

Conditions
Depression, UnipolarTreatment Resistant Depression
Interventions
DRUG

PF-04995274

PF-04995274 tablets

DRUG

Placebo Oral Tablet

Placebo tablet, identical appearance to experimental tablet

Trial Locations (1)

OX3 7JX

University of Oxford, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT03515733 - PF-04995274 and Emotional Processing in Treatment Resistant Depression | Biotech Hunter | Biotech Hunter